Vnitr Lek 2016, 62(2):152-156

Severe osteoporosis - the story of chronic medication-related hyponatremia

Pavel Polák1,2,3,*, Petr Husa1, Hana Matějovská Kubešová2
1 Klinika infekčních chorob LF MU a FN Brno
2 Klinika interní, geriatrická, ošetřovatelství a praktického lékařství LF MU a FN Brno
3 Oddělení klinické hematologie FN Brno

The authors present a case-report of a 73years old woman treated for arterial hypertension within past 15 years with diuretics (thiazides, amiloride and indapamide) and concomitantly with antidepressive trazodone. The patient developed severe osteoporosis after 6 years of such a treatment with multiple fractures even after minor trauma; during whole this period severe hyponatremia without adequate supplementation was documented. Most probably, there exists tight relationship of osteoporosis and hyponatremia in this patient - the authors discuss possible pathophysiological mechanisms at the level of renal tubules, osteoblasts and osteoclasts, hypopituitary-skeletal axis, syndrome of inadequate adiuretin secretion (SIADH) and possible influence of acid-base balance disturbances.

Keywords: alkalosis; antidepressive drugs; diuretics; hyponatremia; osteoporosis

Received: July 29, 2015; Accepted: October 30, 2015; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P, Husa P, Matějovská Kubešová H. Severe osteoporosis - the story of chronic medication-related hyponatremia. Vnitr Lek. 2016;62(2):152-156.
Download citation

References

  1. Sakhaee K, Maalouf NM, Kumar R et al. Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 2011; 79(4): 393-403. Go to original source... Go to PubMed...
  2. Ayus JC, Negri AL, Kalantar-Zadeh K et al. Is chronic hyponatremia a novel risk factor for hip fracture in the elderly? Nephrol Dial Transplant 2012; 27(10): 3725-3731. Go to original source... Go to PubMed...
  3. Žofková I. Léky indukovaná osteoporóza. Vnitř Lék 2013; 59(1): 59-63. Go to PubMed...
  4. Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009; 84(2): 103-111. Go to original source... Go to PubMed...
  5. Javed F, Khan SA, Ayers EW et al. Association of hypertension and bone mineral density in an elderly African American female population. J Natl Med Assoc 2012; 104(3-4): 172-178. Go to original source... Go to PubMed...
  6. Aluoch AO, Jessee R, Habal H et al. Heart failure as a risk factor for osteoporosis and fractures. Curr Osteoporos Rep 2012; 10(4): 258-269. Go to original source... Go to PubMed...
  7. Ilić K, Obradović N, Vujasinović-Stupar N. The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int 2013; 92(3): 217-227. Go to original source... Go to PubMed...
  8. Kann PH, Hadji P, Bergmann RS. Osteoporose jenseits von Kortison. Z Rheumatol 2014; 73(4): 323-328. Go to original source... Go to PubMed...
  9. Tamma R, Sun L, Cuscito C et al. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci USA 2013; 110(46): 18644-18649. Dostupné z DOI: <http://dx.doi.org/10.1073/pnas.1318257110>. Go to original source... Go to PubMed...
  10. Hannon MJ, Verbalis JG. Sodium homeostasis and bone. Curr Opin Nephrol Hypertens 2014; 23(4): 370-376. Go to original source... Go to PubMed...
  11. Lawson EA, Fazeli PK, Calder G et al. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. J Clin Psychiatry 2012; 73: e1379-e1383. Dostupné z DOI: <http://dx.doi.org/10.4088/JCP.12m07919>. Go to original source... Go to PubMed...
  12. Hoorn EJ, Rivadeneira F, van Meurs JBJ et al. Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J Bone Miner Res 2011; 26(8): 1822-1828. Go to original source... Go to PubMed...
  13. Miriam Rachel Usala G, Fernandez SJ, Mete M et al. Hyponatremia is associated with increased osteoporosis and bone fractures in a large U. S. health system population. J Clin Endocrinol Metab 2015; 100(8):3021-3031. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2015-1261>. Go to original source... Go to PubMed...
  14. Kruse C, Eiken P, Vestergaard P. Hyponatremia and osteoporosis: insights from the Danish National Patient Registry. Osteoporos Int 2015; 26(3): 1005-1016. Go to original source... Go to PubMed...
  15. Kwak MK, Choi D, Lee JH et al. Relationship between decrease in serum sodium level and bone mineral density in osteoporotic fracture patients. J Bone Metab 2015; 22(1): 9-15. Go to original source... Go to PubMed...
  16. Afshinnia F, Sundaram B, Ackermann RJ et al. Hyponatremia and osteoporosis: reappraisal of a novel association. Osteoporos Int 2015; 26(9): 2291-2298. Go to original source... Go to PubMed...
  17. Li WG, Yu Y, Huang C et al. Nonproton ligand sensing domain is required for paradoxical stimulation of acid-sensing ion channel 3 (ASIC3) channels by amiloride. J Biol Chem 2011; 286(49): 42635-42646. Dostupné z DOI: <http://dx.doi.org/10.1074/jbc.M111.289058>. Go to original source... Go to PubMed...
  18. Weinstein AM. A mathematical model of distal nephron acidification: diuretic effects. Am J Physiol Renal Physiol 2008; 295(5): F1353-F1364. Go to original source... Go to PubMed...
  19. Kopp KF. Das Bikarbonat-Mangel-Syndrom, Bicarbonate-Deficiency-Syndrome (BDS). Der Bikarbonat-Alkalisch-Plus-BONUS (BBAPB). Tägliche Bikarbonat-Substitution, Wirkung und Nutzen für Wohlbefinden und Gesundheit im Allgemeinen und in der Medizin. Dostupné z WWW: <http://www.kf-kopp.de/wissenschaftliche-arbeiten/das-bikarbonat-mangel-syndrom-bicarbonate-deficiencysyndrome-bds/>.
  20. Bhuvaneswar CG, Baldessarini RJ, Harsh VL et al. Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. CNS Drugs 2009; 23(12): 1003-1021. Go to original source... Go to PubMed...
  21. Bonny O, Edwards A. Calcium reabsorption in the distal tubule: regulation by sodium, pH, and flow. Am J Physiol Renal Physiol 2013; 304(5): F585-F600. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.